Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy

Abstract Background This study aimed to identify potential predictive factors for the survival of advanced non small-cell lung cancer (NSCLC) patients undergoing first-line platinum-based chemotherapy. Methods A total of 270 advanced NSCLC patients who underwent first-line platinum-based chemotherap...

Full description

Bibliographic Details
Main Authors: Jun Ying, Danfei Zhou, Tongjie Gu, Jianda Huang, Haijian Liu
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Cancer
Subjects:
Non small-cell lung cancers
Chemotherapy
Prognosis
Albumin-to-fibrinogen ratio
Online Access:http://link.springer.com/article/10.1186/s12885-019-5490-y

Internet

http://link.springer.com/article/10.1186/s12885-019-5490-y

Similar Items